Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS

NCT00002940 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: hydroxyurea

Sponsor

St. Jude Children's Research Hospital